Stay updated on Dauno/Cytarabine ± Uproleselan in AML Clinical Trial

Sign up to get notified when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Footer updates: added 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.
    Difference
    0.0%
    Check dated 2025-12-23T21:07:00.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.3.2 has been added as the latest entry and Revision: v3.2.0 has been removed from the history.
    Difference
    0.0%
    Check dated 2025-11-25T11:53:50.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Deleted an administrative banner about government funding status and NIH operating status from the page. This change does not affect core study information or how users interact with the page.
    Difference
    0.1%
    Check dated 2025-11-18T07:19:11.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The history now includes entries for 2025-10-28 and 2025-10-29, and 2025-10-09 was removed; this change only updates the record history UI rather than the trial data or status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:33:17.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Additions introduce a new study-related entry and dates; deletions remove an earlier date. Net effect: page gains substantive study content and a new timestamp while an older date is removed.
    Difference
    0.4%
    Check dated 2025-10-13T11:56:20.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    Additions introduce a government operating-status notice and a new version (v3.2.0); deletions remove the previous version (v3.1.0) and an older date marker. Overall, the page now reflects current operating status and the latest revision.
    Difference
    4%
    Check dated 2025-10-06T07:58:46.000Z thumbnail image

Stay in the know with updates to Dauno/Cytarabine ± Uproleselan in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.